Keyphrases
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
15%
Adolescent Obesity
13%
Body Mass Index
17%
Cardiovascular Risk
23%
Cognitive Decline
13%
Cognitive Dysfunction
35%
Cognitive Function
60%
Cognitive Impairment
34%
Cognitive Performance
20%
Cognitive Score
13%
Dementia
17%
Dementia Risk
12%
Diabetes
73%
Diabetes Risk
13%
Digit Symbol Substitution Test
19%
Dulaglutide
13%
During Pregnancy
13%
Dysglycemia
30%
Early-onset Type 2 Diabetes
27%
Gestational Diabetes
13%
Glargine
21%
Glucose Control
18%
Glucose Intolerance
17%
Hazard Ratio
20%
Hypoglycemia
13%
Intervention Studies
19%
Intranasal Insulin
17%
Israeli
18%
Late Adolescence
20%
Meta-analysis
12%
Metabolic Syndrome
12%
Mini-Mental State Examination
17%
Morbid Obesity
14%
Obesity
17%
Older Adults
40%
Older People
30%
Omega-3 Fatty Acids
12%
Oral Glucose Tolerance Test
12%
Patients with Diabetes
53%
Placebo
13%
Pregestational Diabetes
12%
Randomized Controlled Trial
22%
Risk Factors
18%
Risk Study
12%
Systematic Meta-analysis
12%
Thyroid Eye Disease
12%
Type 1 Diabetes Mellitus (T1DM)
33%
Type 2 Diabetes Mellitus (T2DM)
78%
Type I Diabetes
22%
Young Adulthood
17%
Medicine and Dentistry
Adolescent
22%
Adolescent Obesity
6%
Alzheimer's Disease
5%
Apoplexy
18%
Birth Weight
9%
Body Mass Index
42%
Cardiovascular Disease
10%
Cardiovascular Risk
8%
Cardiovascular System
17%
Childbirth
6%
Cognition
33%
Cognitive Defect
32%
Cohort Analysis
24%
Diabetes
100%
Diabetes Mellitus
16%
Digit Symbol Substitution Test
8%
Disease
7%
Disease Management
8%
Dulaglutide
13%
Dysglycemia
14%
Endocrine Ophthalmopathy
12%
Gestational Diabetes
15%
Hazard Ratio
14%
Hypoglycemia
7%
Insulin Dependent Diabetes Mellitus
22%
Insulin Glargine
8%
Insulin Pump
8%
Linear Regression Analysis
6%
Maturity Onset Diabetes of the Young
61%
Meta-Analysis
8%
Metabolic Syndrome
12%
Mini-Mental State Examination
7%
Montreal Cognitive Assessment
12%
Morbid Obesity
7%
Myocardial Infarction
12%
Neonatal Hypoglycemia
8%
Neonate
7%
Obesity
14%
Odds Ratio
8%
Omega-3 Fatty Acid
8%
Physical Capacity
5%
Placebo
15%
Prevalence
11%
Prevention of Dementia
6%
Primary Health Care
8%
Quality of Life
7%
Randomized Controlled Trial
17%
Semaglutide
6%
Type 1 Diabetes
5%
Type 2 Diabetes
8%
Nursing and Health Professions
Blood Pressure
11%
Cardiovascular Disease
19%
Cardiovascular Risk
18%
Cognitive Defect
32%
Cohort Analysis
20%
Combination Therapy
6%
Comorbidity
6%
Confidence Interval
5%
Cyclorphan
8%
Diabetes Mellitus
16%
Digit Symbol Substitution Test
9%
Disease Management
8%
Dysglycemia
12%
Frailty
9%
Glucose Blood Level
17%
Hazard Ratio
11%
Heart Failure
5%
Hemoglobin A1c
5%
Home Care
6%
Hypoglycemia
7%
Insulin Dependent Diabetes Mellitus
12%
Insulin Glargine
8%
Insulin Pump
8%
Lipid Blood Level
5%
Meta Analysis
8%
Mini Mental State Examination
9%
Montreal Cognitive Assessment
6%
Non Insulin Dependent Diabetes Mellitus
42%
Obesity
8%
Omega-3 Fatty Acid
8%
Patient with Diabetes
12%
Placebo
7%
Practice Guideline
5%
Primary Medical Care
8%
Quality of Life
7%
Self Care
18%
Systematic Review
8%
Telmisartan
5%